Viewing Study NCT04439266


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-28 @ 6:11 PM
Study NCT ID: NCT04439266
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2020-06-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)
Sponsor: National Cancer Institute (NCI)
Organization: